Healthcare -
Biotechnology - NASDAQ - US
$ 3.12
-8.5 %
$ 529 M
Market Cap
-1.32
P/E
RLAY - SHORT-TERM DEBT
Short-term Debt RLAY - Relay Therapeutics, Inc.
4.96 M
LAST VALUE
16.02%
2 YEAR CAGR
94.57%
5 YEAR CAGR
0.00%
10 YEAR CAGR